C8 Galactosylceramide (d18:1/8:0), CAS [[41613-16-5]]

Produktübersicht

• Artikelname: C8 Galactosylceramide (d18:1/8:0), CAS [[41613-16-5]]
• Artikelnummer: TGM-T36323
• Hersteller Artikelnummer: T36323
• Alternativnummer: TGM-T36323-10MG
• Hersteller: TargetMol
• Kategorie: Biochemikalien
• Alternative Synonym: C8 Galactosylceramide (d18:1/8:0)

Produktbeschreibung

C8 Galactosylceramide is a synthetic C8 short-chain derivative of known membrane microdomain-forming sphingolipids. It increases the amount delivered and toxicity of doxorubicin in cancerous but not non-cancerous cells when incorporated into the nanoliposomal membrane of nanoliposomal-doxorubicin. C8 Galactosylceramide induces proliferation and cytokine production by splenocytes in vitro at concentrations ranging from 100-1,000 ng/ml but has no effect on natural killer T cell production in vivo. It also activates NF-kappaB production in C6 glioma cells when used at a concentration of 10 µM.

Produkteigenschaften

• Molekulargewicht: 587.83
• CAS Nummer: [41613-16-5]
• Formel: C32H61NO8
• Target-Kategorie: Others

Bilder

T36323